2026 Global: Angioplasty Balloons Market -Competitive Review (2032) report
Description
The 2026 Global: Angioplasty Balloons Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for angioplasty balloons market by geography and historical trend. The scope of the report extends to sizing of the angioplasty balloons market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Boston Scientific, Abbott Laboratories, Terumo Corporation, BIOTRONIK, B. Braun, Cook Medical, Johnson & Johnson (Cordis), Philips, and AngioDynamics are widely recognized as ten major companies competing in the global angioplasty balloons market. Medtronic and Boston Scientific are frequently cited as market leaders with extensive product portfolios that include drug-coated balloons, scoring and cutting balloons, and specialized catheter systems, supporting broad clinical applications across coronary and peripheral interventions. Abbott and Terumo hold significant positions through established PTCA and dilation catheter lines and regional distribution strength, while BIOTRONIK is noted for its precision-engineered cardiovascular devices and presence in Europe and emerging markets. B. Braun and Cook Medical serve important roles in offering a diverse range of interventional products and procedural support tools used by hospitals and ambulatory surgical centers, often focusing on product reliability and procedural compatibility. Johnson & Johnson’s Cordis unit and Philips (including assets from Spectranetics) provide competitive niche and specialty balloons, particularly in drug-coated and device-integrated solutions that address restenosis and complex lesion anatomies. AngioDynamics, Merit Medical, MicroPort, and several smaller regional players also contribute to market breadth through targeted innovations, cost-competitive offerings, and localized service networks that complement the larger multinational manufacturers.
These companies compete across technology, regulatory approvals, and channel reach, with drug-coated balloons (DCBs), scoring and cutting balloon technologies, and material advancements (e.g., more flexible, biocompatible polymers) driving product differentiation and clinical adoption. Strategic activity among the ten includes R&D investments in DCBs to reduce restenosis, portfolio expansions through acquisitions or partnerships (notably Philips’ expansion into specialty balloon segments), and commercialization strategies that leverage hospital and ambulatory surgical center penetration where hospitals account for the majority of angioplasty balloon revenues. Regional market dynamics favor North America for market size and reimbursement support, while Asia‑Pacific is identified as the fastest-growing region as manufacturers (including the listed companies) expand distribution and regulatory filings to capture rising procedural volumes and medical infrastructure investments. Pricing pressure and the need for evidence from randomized and real-world studies shape go‑to‑market decisions, with leading firms emphasizing clinical data, device compatibility with existing catheter platforms, and training programs for interventional cardiologists.
Market concentration and future positioning hinge on product innovation, regulatory outcomes, and service ecosystems that support minimally invasive cardiovascular care. The major firms listed maintain competitive advantages through scale, global manufacturing and supply chains, and integrated offerings that pair balloons with adjunctive devices and imaging tools, enabling bundled solutions for percutaneous coronary and peripheral interventions. Emerging players and regional manufacturers challenge incumbents on cost and niche technologies (for example, specialized peripheral DCBs or cutting balloons for complex lesions), prompting the established companies to pursue lifecycle management, targeted clinical trials, and localized market strategies to protect share and address unmet clinical needs across diverse healthcare systems.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for angioplasty balloons market by geography and historical trend. The scope of the report extends to sizing of the angioplasty balloons market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Boston Scientific, Abbott Laboratories, Terumo Corporation, BIOTRONIK, B. Braun, Cook Medical, Johnson & Johnson (Cordis), Philips, and AngioDynamics are widely recognized as ten major companies competing in the global angioplasty balloons market. Medtronic and Boston Scientific are frequently cited as market leaders with extensive product portfolios that include drug-coated balloons, scoring and cutting balloons, and specialized catheter systems, supporting broad clinical applications across coronary and peripheral interventions. Abbott and Terumo hold significant positions through established PTCA and dilation catheter lines and regional distribution strength, while BIOTRONIK is noted for its precision-engineered cardiovascular devices and presence in Europe and emerging markets. B. Braun and Cook Medical serve important roles in offering a diverse range of interventional products and procedural support tools used by hospitals and ambulatory surgical centers, often focusing on product reliability and procedural compatibility. Johnson & Johnson’s Cordis unit and Philips (including assets from Spectranetics) provide competitive niche and specialty balloons, particularly in drug-coated and device-integrated solutions that address restenosis and complex lesion anatomies. AngioDynamics, Merit Medical, MicroPort, and several smaller regional players also contribute to market breadth through targeted innovations, cost-competitive offerings, and localized service networks that complement the larger multinational manufacturers.
These companies compete across technology, regulatory approvals, and channel reach, with drug-coated balloons (DCBs), scoring and cutting balloon technologies, and material advancements (e.g., more flexible, biocompatible polymers) driving product differentiation and clinical adoption. Strategic activity among the ten includes R&D investments in DCBs to reduce restenosis, portfolio expansions through acquisitions or partnerships (notably Philips’ expansion into specialty balloon segments), and commercialization strategies that leverage hospital and ambulatory surgical center penetration where hospitals account for the majority of angioplasty balloon revenues. Regional market dynamics favor North America for market size and reimbursement support, while Asia‑Pacific is identified as the fastest-growing region as manufacturers (including the listed companies) expand distribution and regulatory filings to capture rising procedural volumes and medical infrastructure investments. Pricing pressure and the need for evidence from randomized and real-world studies shape go‑to‑market decisions, with leading firms emphasizing clinical data, device compatibility with existing catheter platforms, and training programs for interventional cardiologists.
Market concentration and future positioning hinge on product innovation, regulatory outcomes, and service ecosystems that support minimally invasive cardiovascular care. The major firms listed maintain competitive advantages through scale, global manufacturing and supply chains, and integrated offerings that pair balloons with adjunctive devices and imaging tools, enabling bundled solutions for percutaneous coronary and peripheral interventions. Emerging players and regional manufacturers challenge incumbents on cost and niche technologies (for example, specialized peripheral DCBs or cutting balloons for complex lesions), prompting the established companies to pursue lifecycle management, targeted clinical trials, and localized market strategies to protect share and address unmet clinical needs across diverse healthcare systems.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.